HopeStage
Back to all studies
Active Not RecruitingNCT05562349

Clavulanic acid or placebo for cocaine use

About this title

Clavulanic Acid for the Treatment of Cocaine Use Disorder

Read the official source — NCT05562349
Medication studyAges 18–70United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
Philadelphia and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 3, 2023
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
65
Sponsor
Temple University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT05562349
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled Phase 2a Pilot Study to Assess the Efficacy and Safety of Clavulanic Acid vs. Placebo for the Treatment of Cocaine Use Disorder

Recruitment & locations

Not recruiting

Philadelphia · Charleston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Temple University, a university.

Does this study involve medication?

Yes. The study involves medication, including Clavulanic Acid Only Product and Placebo.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies